National Bank of Canada
FBRX

National Bank of Canada’s Forte Biosciences FBRX Stock Holding History

National Bank of Canada’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2K Buy
572
+94
+20% +$2.23K ﹤0.01% 2371
2026
Q1 		$12.4K Buy
478
+402
+529% +$11.6K ﹤0.01% 2282
2025
Q4 		$2.07K Buy
+76
New +$1.33K ﹤0.01% 2559

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

National Bank of Canada's FBRX Position: Q2 2026 in Review

National Bank of Canada increased its Forte Biosciences (FBRX) stake by 20% in Q2 2026, buying an estimated $2.23K and bringing the position to 572 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2371.

National Bank of Canada first reported a position in FBRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $12.4K in Q1 2026. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • National Bank of Canada held 572 shares of Forte Biosciences worth $12.2K as of Q2 2026.
  • National Bank of Canada bought 94 Forte Biosciences shares in Q2 2026, an estimated $2.23K.
  • Forte Biosciences made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2371 holding.
  • National Bank of Canada first reported a position in Forte Biosciences in Q4 2025 and has held it in 3 quarters since.
  • National Bank of Canada's Forte Biosciences position peaked at $12.4K in Q1 2026.
  • 86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.